Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis
Clinical trial NCT03598036 · TERMINATED
Trial details
- NCT number
- NCT03598036
- Sponsor
- Aurinia Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2020-05-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.